Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Elizabeth J. Killiam"'
Autor:
Dimitrios Dougenis, Daniel J. Boffa, Konstantinos N. Syrigos, Vassiliki Zolota, Taxiarchis Botsis, Mark Gustavson, Elizabeth J. Killiam, Scott N. Gettinger, Robert J. Homer, David L. Rimm, Lynn T. Tanoue, Frank C. Detterbeck, Valsamo Anagnostou, Gerold Bepler, Anastasios Dimou
Publikováno v:
Cancer. 118:1607-1618
BACKGROUND: The importance of definitive histological subclassification has increased as drug trials have shown benefit associated with histology in nonsmall-cell lung cancer (NSCLC). The acuity of this problem is further exacerbated by the use of mi
Autor:
David L. Rimm, Fan Zhang, Elizabeth J. Killiam, Steven M. Frisch, Sanjeev Kumar, Sun Hee Park, Benjamin Cieply, Jane E. Schupp
Publikováno v:
Molecular and cellular biology. 31(19)
Detachment of epithelial cells from matrix or attachment to an inappropriate matrix engages an apoptotic response known as anoikis, which prevents metastasis. Cellular sensitivity to anoikis is compromised during the oncogenic epithelial-to-mesenchym
Autor:
Maria T Baquero, David L. Rimm, Robert L. Camp, Seema Agarwal, Jason A. Hanna, Elizabeth J. Killiam
Publikováno v:
Cancer Research. 70:1753-1753
INTRODUCTION: Taxanes are microtubule targeting agents (MTAs) and potent cytotoxic molecules recognized as highly effective chemotherapeutic agents. In large randomized clinical trials, taxane-based chemotherapies provided benefits in overall and dis
Autor:
Dimitrios Dougenis, Vassiliki Zolota, Lynn T. Tanoue, Konstantinos N. Syrigos, Valsamo Anagnostou, Panagiota Kolokytha, Anastasios Dimou, Konstantina Frangia, Frank C. Detterbeck, David L. Rimm, Elizabeth J. Killiam, Gerold Bepler
Publikováno v:
Cancer Research. 70:4643-4643
Primary lung squamous cell carcinomas (SCC) form a distinct group in terms of molecular characteristics. There is no single assay that predicts outcome and selects optimal treatment for early stage SCC, especially for stage I where there is a 33-60%